(S)-nicotine increases expression ISO RGD:1317414 6480464 Nicotine results in increased expression of CLDN4 protein CTD PMID:31783125 (S)-nicotine decreases expression ISO RGD:1317414 6480464 Nicotine results in decreased expression of CLDN4 protein CTD PMID:31783125 1,2-dimethylhydrazine increases expression ISO RGD:1317414 6480464 1, 2-Dimethylhydrazine results in increased expression of CLDN4 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CLDN4 mRNA CTD PMID:20551477 , PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:1317414 6480464 Ethinyl Estradiol results in increased expression of CLDN4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1317414 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN4 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1317413 6480464 Estradiol results in decreased expression of CLDN4 mRNA, Estradiol results in decreased expression of CLDN4 protein CTD PMID:16474171 , PMID:21761342 17beta-estradiol multiple interactions ISO RGD:1317413 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CLDN4 mRNA CTD PMID:30165855 17beta-estradiol affects expression ISO RGD:1317414 6480464 Estradiol affects the expression of CLDN4 mRNA CTD PMID:15598610 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1317414 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1317414 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317414 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN4 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CLDN4 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1317413 6480464 Tetrachlorodibenzodioxin results in decreased expression of CLDN4 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317413 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of CLDN4 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317414 6480464 Tetrachlorodibenzodioxin affects the expression of CLDN4 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317414 6480464 Tetrachlorodibenzodioxin results in increased expression of CLDN4 mRNA CTD PMID:17942748 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CLDN4 mRNA CTD PMID:17187413 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1317414 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of CLDN4 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:1317414 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of CLDN4 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1317414 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of CLDN4 exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:1317414 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CLDN4 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:1317414 6480464 Fenretinide results in increased expression of CLDN4 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:1317413 6480464 Fenretinide results in increased expression of CLDN4 mRNA CTD PMID:16671099 5-fluorouracil affects response to substance ISO RGD:1317413 6480464 CLDN4 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil decreases expression ISO RGD:1317413 6480464 Fluorouracil results in decreased expression of CLDN4 protein CTD PMID:15352031 acetamide increases expression EXP 6480464 acetamide results in increased expression of CLDN4 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1317414 6480464 [Ovalbumin co-treated with Acrolein] results in increased expression of CLDN4 protein CTD PMID:30608172 acrolein increases expression ISO RGD:1317414 6480464 Acrolein results in increased expression of CLDN4 protein CTD PMID:30608172 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of CLDN4 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1317414 6480464 Aflatoxin B1 results in increased expression of CLDN4 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1317414 6480464 Tretinoin results in increased expression of CLDN4 mRNA CTD PMID:16236135 all-trans-retinoic acid multiple interactions ISO RGD:1317414 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of CLDN4 mRNA more ... CTD PMID:30951980 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CLDN4 mRNA CTD PMID:20488242 anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Cyclophosphamide results in decreased expression of CLDN4 protein] CTD PMID:25451569 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA], pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] CTD PMID:23816505 aristolochic acid A increases expression ISO RGD:1317413 6480464 aristolochic acid I results in increased expression of CLDN4 mRNA CTD PMID:33212167 arsane increases expression ISO RGD:1317413 6480464 Arsenic results in increased expression of CLDN4 mRNA, Arsenic results in increased expression of CLDN4 protein CTD PMID:24349408 arsane affects localization ISO RGD:1317414 6480464 Arsenic affects the localization of CLDN4 protein CTD PMID:24349408 arsenic atom increases expression ISO RGD:1317413 6480464 Arsenic results in increased expression of CLDN4 mRNA, Arsenic results in increased expression of CLDN4 protein CTD PMID:24349408 arsenic atom affects localization ISO RGD:1317414 6480464 Arsenic affects the localization of CLDN4 protein CTD PMID:24349408 arsenite(3-) increases expression ISO RGD:1317414 6480464 arsenite results in increased expression of CLDN4 mRNA CTD PMID:18191166 arsenous acid decreases response to substance ISO RGD:1317413 6480464 CLDN4 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 benzo[a]pyrene decreases expression ISO RGD:1317414 6480464 Benzo(a)pyrene results in decreased expression of CLDN4 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1317413 6480464 Benzo(a)pyrene results in decreased methylation of CLDN4 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1317413 6480464 Benzo(a)pyrene results in decreased expression of CLDN4 mRNA CTD PMID:31255691 benzo[a]pyrene increases expression ISO RGD:1317413 6480464 Benzo(a)pyrene results in increased expression of CLDN4 mRNA CTD PMID:20106945 more ... benzo[e]pyrene increases methylation ISO RGD:1317413 6480464 benzo(e)pyrene results in increased methylation of CLDN4 promoter CTD PMID:30157460 beta-naphthoflavone increases expression ISO RGD:1317413 6480464 beta-Naphthoflavone results in increased expression of CLDN4 mRNA CTD PMID:32151702 bisphenol A decreases expression ISO RGD:1317413 6480464 bisphenol A results in decreased expression of CLDN4 mRNA CTD PMID:16474171 bisphenol A decreases expression ISO RGD:1317414 6480464 bisphenol A results in decreased expression of CLDN4 mRNA CTD PMID:33485121 bisphenol A multiple interactions ISO RGD:1317414 6480464 4-methyl-N1-(3-phenylpropyl)benzene-1 more ... CTD PMID:30951980 , PMID:33485121 bisphenol A increases expression ISO RGD:1317414 6480464 bisphenol A results in increased expression of CLDN4 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CLDN4 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1317414 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of CLDN4 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1317414 6480464 bisphenol F results in increased expression of CLDN4 mRNA CTD PMID:30951980 bleomycin A2 increases expression ISO RGD:1317414 6480464 Bleomycin results in increased expression of CLDN4 mRNA CTD PMID:26345256 butanal increases expression ISO RGD:1317413 6480464 butyraldehyde results in increased expression of CLDN4 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:1317413 6480464 Cadmium Chloride results in increased expression of CLDN4 mRNA CTD PMID:25851441 , PMID:25882684 calcitriol increases expression ISO RGD:1317413 6480464 Calcitriol results in increased expression of CLDN4 mRNA CTD PMID:26485663 cannabidiol increases expression ISO RGD:1317413 6480464 Cannabidiol results in increased expression of CLDN4 protein CTD PMID:32656944 carbon nanotube affects expression ISO RGD:1317414 6480464 Nanotubes, Carbon analog affects the expression of CLDN4 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1317414 6480464 Nanotubes, Carbon results in increased expression of CLDN4 mRNA CTD PMID:25554681 chloroprene increases expression ISO RGD:1317414 6480464 Chloroprene results in increased expression of CLDN4 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of CLDN4 mRNA CTD PMID:25019507 choline multiple interactions ISO RGD:1317414 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA CTD PMID:20938992 cisplatin increases response to substance ISO RGD:1317413 6480464 CLDN4 protein results in increased susceptibility to Cisplatin CTD PMID:23053666 cisplatin increases import ISO RGD:1317413 6480464 CLDN4 protein results in increased import of Cisplatin CTD PMID:23053666 cisplatin multiple interactions ISO RGD:1317413 6480464 [CLDN4 protein results in increased expression of SLC31A1 protein] which results in increased import of Cisplatin CTD PMID:23053666 copper atom increases abundance ISO RGD:1317413 6480464 CLDN4 protein results in increased abundance of Copper CTD PMID:23053666 copper atom multiple interactions ISO RGD:1317413 6480464 [CLDN4 protein results in increased abundance of Copper] promotes the reaction [[TYR protein results in increased oxidation of Levodopa] which results in increased chemical synthesis of Melanins], [CLDN4 protein results in increased expression of SLC31A1 protein] which results in increased import of and results in increased abundance of Copper CTD PMID:23053666 copper(0) increases abundance ISO RGD:1317413 6480464 CLDN4 protein results in increased abundance of Copper CTD PMID:23053666 copper(0) multiple interactions ISO RGD:1317413 6480464 [CLDN4 protein results in increased abundance of Copper] promotes the reaction [[TYR protein results in increased oxidation of Levodopa] which results in increased chemical synthesis of Melanins], [CLDN4 protein results in increased expression of SLC31A1 protein] which results in increased import of and results in increased abundance of Copper CTD PMID:23053666 copper(II) sulfate increases expression ISO RGD:1317413 6480464 Copper Sulfate results in increased expression of CLDN4 mRNA CTD PMID:19549813 coumarin decreases expression ISO RGD:1317413 6480464 coumarin analog results in decreased expression of CLDN4 mRNA CTD PMID:32578917 coumestrol multiple interactions ISO RGD:1317413 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1317413 6480464 Asbestos, Crocidolite results in increased expression of CLDN4 mRNA CTD PMID:25351596 cyclophosphamide multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Cyclophosphamide results in decreased expression of CLDN4 protein], Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of CLDN4 protein] CTD PMID:25451569 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of CLDN4 protein CTD PMID:25451569 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CLDN4 mRNA CTD PMID:21865292 cyclosporin A increases expression ISO RGD:1317413 6480464 Cyclosporine results in increased expression of CLDN4 mRNA CTD PMID:25562108 , PMID:27989131 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CLDN4 mRNA CTD PMID:21865292 deoxynivalenol increases expression ISO RGD:1317413 6480464 deoxynivalenol results in increased expression of CLDN4 mRNA CTD PMID:20362602 , PMID:24568843 deoxynivalenol decreases expression ISO RGD:1317413 6480464 deoxynivalenol results in decreased expression of CLDN4 protein CTD PMID:19289138 , PMID:20362602 deoxynivalenol increases expression ISO RGD:1317414 6480464 deoxynivalenol results in increased expression of CLDN4 mRNA CTD PMID:24568843 deoxynivalenol multiple interactions ISO RGD:1317413 6480464 deoxynivalenol results in decreased expression of and affects the localization of CLDN4 protein CTD PMID:24568843 dexamethasone multiple interactions ISO RGD:1317413 6480464 Dexamethasone affects the reaction [IL1B protein affects the expression of CLDN4 mRNA] CTD PMID:35405071 diallyl disulfide decreases expression ISO RGD:1317413 6480464 diallyl disulfide results in decreased expression of CLDN4 mRNA, diallyl disulfide results in decreased expression of CLDN4 protein CTD PMID:20600798 diallyl trisulfide decreases expression ISO RGD:1317413 6480464 diallyl trisulfide results in decreased expression of CLDN4 mRNA, diallyl trisulfide results in decreased expression of CLDN4 protein CTD PMID:24084732 diarsenic trioxide decreases response to substance ISO RGD:1317413 6480464 CLDN4 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA], diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] CTD PMID:23816505 dibenzo[a,l]pyrene decreases expression ISO RGD:1317413 6480464 dibenzo(a, l)pyrene results in decreased expression of CLDN4 mRNA CTD PMID:31255691 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CLDN4 mRNA CTD PMID:24893172 dioxygen multiple interactions ISO RGD:1317414 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLDN4 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1317414 6480464 Doxorubicin affects the expression of CLDN4 mRNA CTD PMID:15033991 elemental selenium increases expression ISO RGD:1317413 6480464 Selenium results in increased expression of CLDN4 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CLDN4 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1317413 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA CTD PMID:19167446 ethanol multiple interactions ISO RGD:1317413 6480464 Ethanol results in decreased expression of and affects the localization of CLDN4 protein more ... CTD PMID:28412402 flavonoids multiple interactions ISO RGD:1317413 6480464 Flavonoids inhibits the reaction [Ethanol affects the localization of CLDN4 protein], Flavonoids inhibits the reaction [Ethanol results in decreased expression of and affects the localization of CLDN4 protein] CTD PMID:28412402 folic acid multiple interactions ISO RGD:1317414 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA CTD PMID:20938992 fumonisin B1 decreases expression ISO RGD:1317413 6480464 fumonisin B1 results in decreased expression of CLDN4 mRNA CTD PMID:27153755 fumonisin B1 multiple interactions ISO RGD:1317413 6480464 illite inhibits the reaction [fumonisin B1 results in decreased expression of CLDN4 mRNA] CTD PMID:27153755 furan increases expression EXP 6480464 furan results in increased expression of CLDN4 mRNA CTD PMID:26194646 , PMID:27387713 genistein decreases expression ISO RGD:1317413 6480464 Genistein results in decreased expression of CLDN4 mRNA CTD PMID:16474171 genistein decreases expression ISO RGD:1317414 6480464 Genistein results in decreased expression of CLDN4 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CLDN4 mRNA CTD PMID:33387578 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA], Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] CTD PMID:23816505 L-methionine multiple interactions ISO RGD:1317414 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN4 mRNA CTD PMID:20938992 leuprolide decreases expression ISO RGD:1317413 6480464 Leuprolide results in decreased expression of CLDN4 protein CTD PMID:21761342 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CLDN4 mRNA CTD PMID:28801915 megestrol acetate multiple interactions ISO RGD:1317413 6480464 Megestrol Acetate results in decreased expression of and results in increased localization of CLDN4 protein CTD PMID:23095775 megestrol acetate decreases expression ISO RGD:1317413 6480464 Megestrol Acetate results in decreased expression of CLDN4 mRNA CTD PMID:23095775 melanins multiple interactions ISO RGD:1317413 6480464 [CLDN4 protein results in increased abundance of Copper] promotes the reaction [[TYR protein results in increased oxidation of Levodopa] which results in increased chemical synthesis of Melanins] CTD PMID:23053666 mercury dibromide increases expression ISO RGD:1317413 6480464 mercuric bromide results in increased expression of CLDN4 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA CTD PMID:27188386 methapyrilene increases methylation ISO RGD:1317413 6480464 Methapyrilene results in increased methylation of CLDN4 promoter CTD PMID:30157460 methotrexate increases expression ISO RGD:1317413 6480464 Methotrexate results in increased expression of CLDN4 mRNA CTD PMID:21678067 Monobutylphthalate increases expression EXP 6480464 monobutyl phthalate results in increased expression of CLDN4 mRNA CTD PMID:29162477 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA], Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] CTD PMID:23816505 N-acetyl-L-cysteine multiple interactions ISO RGD:1317414 6480464 Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CLDN4 mRNA] CTD PMID:33485121 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1317414 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CLDN4 mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1317414 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CLDN4 mRNA] CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:1317413 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CLDN4 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CLDN4 mRNA CTD PMID:28801915 naphthalene increases expression ISO RGD:1317414 6480464 naphthalene results in increased expression of CLDN4 mRNA CTD PMID:18978301 nicotine decreases expression ISO RGD:1317414 6480464 Nicotine results in decreased expression of CLDN4 protein CTD PMID:31783125 nicotine increases expression ISO RGD:1317414 6480464 Nicotine results in increased expression of CLDN4 protein CTD PMID:31783125 ochratoxin A decreases expression ISO RGD:1317413 6480464 ochratoxin A results in decreased expression of CLDN4 mRNA CTD PMID:27153755 , PMID:30763683 ochratoxin A multiple interactions ISO RGD:1317413 6480464 illite affects the reaction [ochratoxin A results in decreased expression of CLDN4 mRNA] CTD PMID:27153755 okadaic acid increases expression ISO RGD:1317413 6480464 Okadaic Acid results in increased expression of CLDN4 mRNA CTD PMID:30926360 ozone multiple interactions ISO RGD:1317414 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CLDN4 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CLDN4 mRNA CTD PMID:34911549 panobinostat increases expression ISO RGD:1317413 6480464 panobinostat results in increased expression of CLDN4 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA CTD PMID:27188386 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CLDN4 mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CLDN4 mRNA CTD PMID:32680482 patulin affects localization ISO RGD:1317413 6480464 Patulin affects the localization of CLDN4 protein CTD PMID:19013514 PCB138 multiple interactions ISO RGD:1317414 6480464 [2 more ... CTD PMID:25510870 pentanal increases expression ISO RGD:1317413 6480464 pentanal results in increased expression of CLDN4 mRNA CTD PMID:26079696 phenylmercury acetate increases expression ISO RGD:1317413 6480464 Phenylmercuric Acetate results in increased expression of CLDN4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression ISO RGD:1317413 6480464 Tetradecanoylphorbol Acetate results in increased expression of CLDN4 mRNA CTD PMID:19945525 phorbol 13-acetate 12-myristate increases expression ISO RGD:1317414 6480464 Tetradecanoylphorbol Acetate results in increased expression of CLDN4 mRNA CTD PMID:19945525 phosgene affects expression ISO RGD:1317414 6480464 Phosgene affects the expression of CLDN4 mRNA CTD PMID:16300373 phoxim decreases expression EXP 6480464 phoxim results in decreased expression of CLDN4 mRNA CTD PMID:30003487 phoxim multiple interactions EXP 6480464 Vitamin E inhibits the reaction [phoxim results in decreased expression of CLDN4 mRNA] CTD PMID:30003487 pirinixic acid decreases expression ISO RGD:1317414 6480464 pirinixic acid results in decreased expression of CLDN4 mRNA CTD PMID:17426115 progesterone decreases expression ISO RGD:1317413 6480464 Progesterone results in decreased expression of CLDN4 mRNA CTD PMID:18037150 progesterone affects expression ISO RGD:1317414 6480464 Progesterone affects the expression of CLDN4 mRNA CTD PMID:17251523 propanal decreases expression ISO RGD:1317413 6480464 propionaldehyde results in decreased expression of CLDN4 mRNA CTD PMID:26079696 propanal increases expression ISO RGD:1317413 6480464 propionaldehyde results in increased expression of CLDN4 mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:1317413 6480464 Quercetin results in increased expression of CLDN4 mRNA, Quercetin results in increased expression of CLDN4 protein CTD PMID:18492835 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CLDN4 mRNA, Quercetin results in decreased expression of CLDN4 protein CTD PMID:28431985 quercetin multiple interactions ISO RGD:1317413 6480464 Quercetin results in increased expression of and affects the localization of CLDN4 protein CTD PMID:19297429 quercitrin affects expression ISO RGD:1317413 6480464 quercitrin affects the expression of CLDN4 mRNA CTD PMID:25193878 rottlerin multiple interactions ISO RGD:1317413 6480464 rottlerin results in increased expression of and affects the localization of CLDN4 protein CTD PMID:19297429 sanguinarine decreases expression ISO RGD:1317413 6480464 sanguinarine results in decreased expression of CLDN4 protein CTD PMID:19063874 SB 431542 multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1317413 6480464 Selenium results in increased expression of CLDN4 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1317413 6480464 Silicon Dioxide results in increased expression of CLDN4 mRNA CTD PMID:25351596 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [lipopolysaccharide more ... CTD PMID:33774062 sodium arsenite decreases expression ISO RGD:1317413 6480464 sodium arsenite results in decreased expression of CLDN4 mRNA CTD PMID:12634122 sodium arsenite affects localization ISO RGD:1317414 6480464 sodium arsenite affects the localization of CLDN4 protein CTD PMID:24349408 sodium arsenite increases expression ISO RGD:1317413 6480464 sodium arsenite results in increased expression of CLDN4 mRNA, sodium arsenite results in increased expression of CLDN4 protein CTD PMID:24349408 sodium chloride increases expression EXP 6480464 Sodium Chloride results in increased expression of CLDN4 mRNA, Sodium Chloride results in increased expression of CLDN4 protein CTD PMID:23816505 sodium chloride multiple interactions EXP 6480464 [[SP1 protein co-treated with JUN protein] binds to CLDN4 promoter] promotes the reaction [Sodium Chloride results in increased expression of CLDN4 protein] more ... CTD PMID:23816505 sulforaphane increases expression ISO RGD:1317414 6480464 sulforaphane results in increased expression of CLDN4 mRNA CTD PMID:30529165 T-2 toxin multiple interactions ISO RGD:1317413 6480464 illite inhibits the reaction [T-2 Toxin results in decreased expression of CLDN4 mRNA] CTD PMID:27153755 T-2 toxin decreases expression ISO RGD:1317413 6480464 T-2 Toxin results in decreased expression of CLDN4 mRNA CTD PMID:27153755 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of CLDN4 mRNA CTD PMID:21865292 tamoxifen affects response to substance ISO RGD:1317413 6480464 CLDN4 affects the susceptibility to Tamoxifen CTD PMID:19142967 testosterone decreases expression ISO RGD:1317413 6480464 Testosterone deficiency results in decreased expression of CLDN4 mRNA CTD PMID:21761342 testosterone affects expression ISO RGD:1317414 6480464 Testosterone affects the expression of CLDN4 protein CTD PMID:21761342 thalidomide increases expression ISO RGD:1317414 6480464 Thalidomide results in increased expression of CLDN4 mRNA CTD PMID:26217789 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CLDN4 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1317414 6480464 titanium dioxide results in decreased expression of CLDN4 mRNA CTD PMID:23131501 tributylstannane increases expression ISO RGD:1317414 6480464 tributyltin results in increased expression of CLDN4 mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CLDN4 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1317413 6480464 trichostatin A results in increased expression of CLDN4 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA CTD PMID:27188386 triptonide increases expression ISO RGD:1317414 6480464 triptonide results in increased expression of CLDN4 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1317413 6480464 troglitazone results in increased expression of CLDN4 mRNA, troglitazone results in increased expression of CLDN4 protein CTD PMID:19285010 tunicamycin increases expression ISO RGD:1317414 6480464 Tunicamycin results in increased expression of CLDN4 mRNA CTD PMID:17127020 urethane increases expression ISO RGD:1317413 6480464 Urethane results in increased expression of CLDN4 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1317413 6480464 Valproic Acid results in increased expression of CLDN4 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA CTD PMID:27188386 vanadyl sulfate increases expression ISO RGD:1317413 6480464 vanadyl sulfate results in increased expression of CLDN4 mRNA CTD PMID:16330358 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [phoxim results in decreased expression of CLDN4 mRNA] CTD PMID:30003487 vorinostat multiple interactions ISO RGD:1317413 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA CTD PMID:27188386
